subject: CHEBI:135951

subject_name: Pyronaridine

object_name: Plasmodium falciparum malaria


subject: UNII:V16D2ZT7DT

object_name: non-small cell lung carcinoma

tested_intervention: unsure


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: diabetes mellitus, ketosis-prone


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: multiple sclerosis

tested_intervention: yes


subject: UMLS:C1720919

subject_name: Zostavax

object_name: Shingles, CTCAE


subject: CHEBI:82975

subject_name: Naloxegol

object_name: opioid-induced constipation


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Mycosis fungoides refractory


subject: RXCUI:1940699

subject_name: glecaprevir / pibrentasvir Oral Product

object_name: Infection of heart transplant


subject: RXCUI:1940699

object_name: Disorder of transplanted kidney


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Transfusion-Related Acute Lung Injury


subject: CHEBI:188664

subject_name: Omecamtiv Mecarbil

object_name: heart failure


subject: CHEBI:188664

object_name: Heart Failure, CTCAE


subject: CHEBI:9241

subject_name: Spironolactone

object_name: diastolic heart failure


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Heart failure with normal ejection fraction


subject: UMLS:C0592528

subject_name: Daunoxome

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Chronic low back pain


subject: UMLS:C3493499

object_name: Hepatic impairment


subject: UMLS:C1739735

subject_name: Mycograb

object_name: Cryptococcal meningitis


subject: CHEBI:74947

subject_name: Thalidomide

object_name: genetic disease


subject: CHEBI:74947

object_name: Cooley's anemia


subject: CHEBI:74947

object_name: beta thalassemia


subject: CHEBI:74947

object_name: fetal hemoglobin measurement


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Solid Neoplasm


subject: UMLS:C5418073

subject_name: ERK1/2 Inhibitor JSI-1187


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: cervical squamous cell carcinoma


subject: CHEBI:45863

object_name: cervical small cell carcinoma


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: cancer


subject: PUBCHEM.COMPOUND:3080587

object_name: neoplasm


subject: PUBCHEM.COMPOUND:3080587

object_name: malnutrition


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: shoulder impingement syndrome


subject: CHEBI:150712

object_name: Coracohumeral Impingement Syndrome


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Carcinoma breast stage IV


subject: CHEBI:190514


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: rosacea


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:3757

subject_name: Clonidine

object_name: amphetamine abuse


subject: CHEBI:3757

object_name: mood disorder


subject: UMLS:C0042210

subject_name: Vaccines

object_name: viral disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:27470

subject_name: Folic acid

object_name: gout


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: MESH:C000710692

object_name: frontotemporal dementia


subject: MESH:C000710692

object_name: Frontotemporal Lobar Degeneration


subject: MESH:C000710692

object_name: GRN-related frontotemporal dementia


subject: MESH:C000710692

object_name: Alzheimer disease type 1


subject: CHEBI:174615

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:174615

object_name: aplastic anemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: MESH:C040617

subject_name: mesoglycan

object_name: hemorrhoid


subject: MESH:C040617

object_name: Hemorrhoids, CTCAE 3.0


subject: MESH:C040617

object_name: Hemorrhoids, CTCAE 5.0


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: periodontitis


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C5814274

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: pediatric lymphoma


subject: CHEBI:8207

subject_name: Pilocarpine

object_name: dry eye syndrome


subject: CHEBI:8207

object_name: Dry Eye, CTCAE


subject: CHEBI:8207

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:2735

object_name: Bone Mineral Density


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: carcinoma of esophagus


subject: UniProtKB:P53767

object_name: esophageal cancer


subject: UniProtKB:P53767

object_name: Childhood Esophageal Carcinoma


subject: UniProtKB:P53767

object_name: neoplasm of esophagus


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: PR:000002112


subject: PR:000002112


subject: PR:000002112


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: acute pharyngitis


subject: CHEBI:6520

subject_name: Lomustine

object_name: MGMT-Methylated Glioblastoma


subject: CHEBI:6520

object_name: IDH-wildtype glioblastoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Solid carcinoma


subject: UNII:DPT0O3T46P

object_name: bile duct carcinoma


subject: UNII:DPT0O3T46P

object_name: bile duct cancer


subject: PUBCHEM.COMPOUND:3367

object_name: female reproductive organ cancer


subject: PUBCHEM.COMPOUND:3367

object_name: fallopian tube cancer


subject: PUBCHEM.COMPOUND:3367

object_name: peritoneum cancer


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: colorectal cancer


subject: UNII:11Z5AIU653

object_name: colorectal carcinoma


subject: UNII:11Z5AIU653

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: MESH:C000624565

subject_name: ProRoot MTA

object_name: exposure, dental pulp


subject: CHEBI:18132

subject_name: phosphocholine

object_name: T-Cell Lymphoma


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:9150

subject_name: Simvastatin

object_name: impotence


subject: CHEBI:9150

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:9150

object_name: Erectile dysfunction


subject: CHEBI:9150

object_name: C-reactive protein measurement


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: AIDS


subject: UMLS:C1098513


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Agitation, CTCAE 3.0


subject: UNII:2N4O9L084N

object_name: Agitation


subject: UNII:2N4O9L084N

object_name: Agitation, CTCAE 5.0


subject: UNII:2N4O9L084N

object_name: Alzheimer disease type 1


subject: UNII:2N4O9L084N

object_name: Alzheimer disease


subject: CHEBI:33375

subject_name: Gadolinium

object_name: COPD, severe early onset


subject: CHEBI:33375

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: UMLS:C4287659

subject_name: Hyperpolarized Helium 3


subject: UMLS:C4287659


subject: CHEBI:91414

subject_name: Adavosertib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:91414

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:91414

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:91414

object_name: anaplastic oligoastrocytoma


subject: CHEBI:91414

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:91414

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:91414

object_name: anaplastic astrocytoma


subject: CHEBI:91414

object_name: Adult Gliosarcoma


subject: CHEBI:91414

object_name: gliosarcoma


subject: CHEBI:91414

object_name: Childhood Gliosarcoma


subject: CHEBI:135063

subject_name: glycerylphosphorylcholine

object_name: Vascular cognitive impairment


subject: CHEBI:15354

subject_name: Choline


subject: UMLS:C1710686

object_name: thyroid tumor


subject: UMLS:C1710686

object_name: thyroid gland carcinoma


subject: UMLS:C1710686

object_name: thyroid cancer


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: GTOPDB:7385

subject_name: catumaxomab

object_name: Stomach cancer


subject: GTOPDB:7385

object_name: gastric cancer


subject: GTOPDB:7385

object_name: gastric adenocarcinoma


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: GTOPDB:8415

subject_name: tanezumab

object_name: Chronic low back pain


subject: UNII:EQL0E9GCX1


subject: UMLS:C2346819


subject: CHEBI:49868

object_name: neoplasm


subject: PUBCHEM.COMPOUND:18943906

subject_name: Ibuprofen Ibuprofen Ibuprofen

object_name: osteoarthritis


subject: CHEBI:47835

subject_name: levibuprofen


subject: MESH:C478341

object_name: Thrombophilia Related to COVID-19


subject: MESH:C478341

object_name: thrombophilia


subject: MESH:C478341

object_name: Menopause present (finding)


subject: MESH:C478341

object_name: Menopause


subject: UMLS:C1312686

subject_name: Femarelle


subject: UMLS:C1312686


subject: UMLS:C1312686


subject: UMLS:C1312686


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: Crigler-Najjar syndrome


subject: CHEBI:6741

subject_name: Meloxicam

object_name: EXCESS LMW-DNA


subject: UNII:E79ZM68IOZ

object_name: Alzheimer disease type 1


subject: UNII:E79ZM68IOZ

object_name: Alzheimer disease


subject: UMLS:C4508754


subject: UMLS:C4508754


subject: CHEBI:135926

subject_name: Udenafil


subject: UMLS:C2349009

subject_name: Zydena


subject: CHEBI:75551


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: aortic valve disease 2


subject: CHEBI:37941

object_name: aortic stenosis


subject: CHEBI:37941

object_name: aortic valve disease 3


subject: CHEBI:37941

object_name: Stenosis of aorta


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:184023


subject: CHEBI:184023


subject: CHEBI:184023


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: PR:000004321


subject: PR:000004321


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:68558


subject: CHEBI:68558


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: Congenital IGHD


subject: UMLS:C0384570

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Autoimmunity


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Pediatric Obesity


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: cellulitis


subject: CHEBI:29007

object_name: cellulitis on exam (physical finding)


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:52CMI0WC3Y

object_name: Recurrent Glioblastoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:6121

subject_name: Ketamine

object_name: Chronic Condition


subject: CHEBI:6121

object_name: chronic disease


subject: CHEBI:6121

object_name: Chronic Disease


subject: DRUGBANK:DB08937

object_name: pancreatic neoplasm


subject: CHEBI:90876

subject_name: Lonsurf


subject: UNII:M0Q7802G2B

subject_name: Benzodiazepines

object_name: bladder tumor


subject: UNII:M0Q7802G2B

object_name: Postoperative cognitive dysfunction


subject: UMLS:C4048284

subject_name: Benzodiazepine


subject: UMLS:C4048284


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: opioid use


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN


subject: CHEBI:6759

subject_name: Mepivacaine


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:3A58010674

object_name: non-Hodgkin lymphoma


subject: UNII:3A58010674

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:3A58010674

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:2S27T3DSZ3

object_name: herpes zoster


subject: UNII:2S27T3DSZ3

object_name: postherpetic neuralgia


subject: UMLS:C3274916

subject_name: GRASPA


subject: UMLS:C3274916

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3274916

object_name: malignant pancreatic neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Mucosal Melanoma


subject: UNII:DPT0O3T46P

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: non-cutaneous melanoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Non-Cutaneous Melanoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Non-Cutaneous Melanoma


subject: UMLS:C5959683

subject_name: IKZF1/IKZF3 Protein Degrader GLB-002


subject: UMLS:C5959683


subject: UMLS:C5959683


subject: UMLS:C5959683


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: acute myeloid leukemia


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: myeloid leukemia


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: chronic hepatitis B virus infection


subject: UMLS:C4329336


subject: CHEBI:3310

subject_name: Calcium acetate

object_name: hyperphosphatemia


subject: CHEBI:3310

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:3310

object_name: Hyperphosphatemia, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: transplantation infection


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:76607

subject_name: Macitentan

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:11332179

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:11332179

object_name: breast cancer


subject: UMLS:C3640996

subject_name: Uniformly-labeled [13C]glucose


subject: UMLS:C3640996


subject: UMLS:C3640996


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: type 2 diabetes mellitus


subject: CHEBI:37810

subject_name: octadecatetraenoic acid

object_name: osteoporosis


subject: CHEBI:37810

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:37810

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:37810

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:Q1418F39MH

subject_name: TAC 101

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Safety Issues


subject: UMLS:C3827082


subject: UMLS:C5555776

subject_name: Anti-ILT2 Monoclonal Antibody BND-22

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:18319735

object_name: Neurogenic bladder


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: coronary atherosclerosis


subject: CHEBI:68579

object_name: cardiovascular disorder


subject: CHEBI:27594

subject_name: Graphite

object_name: hepatic encephalopathy


subject: CHEBI:5134

subject_name: Fluticasone

object_name: oral candidiasis


subject: CHEBI:5134

object_name: voice disorders


subject: CHEBI:6456

subject_name: Lidocaine

object_name: complex regional pain syndrome


subject: CHEBI:50634

object_name: nephrotic syndrome


subject: CHEBI:50634

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:50634

object_name: Edema


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:75551

object_name: impotence


subject: CHEBI:75551

object_name: Unable to perform sex


subject: UMLS:C5238412

subject_name: SERD ZN-c5

object_name: Childhood Breast Carcinoma


subject: UMLS:C5238412

object_name: breast carcinoma


subject: UMLS:C5238412

object_name: breast cancer


subject: CHEBI:25187

subject_name: Menthol

object_name: actinic keratosis


subject: UNII:2U1A25MKP9

subject_name: SABIRNETUG

object_name: Alzheimer disease type 1


subject: UNII:2U1A25MKP9

object_name: Alzheimer disease


subject: UMLS:C5855375

subject_name: Sabirnetug


subject: UMLS:C5855375


subject: CHEBI:63631

subject_name: Topiramate

object_name: mood disorder


subject: CHEBI:63631

object_name: mental disorder


subject: CHEBI:63631

object_name: psychiatric disorder


subject: CHEBI:63631

object_name: Affective Disorders, Psychotic


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: perinatal necrotizing enterocolitis


subject: DRUGBANK:DB19249

object_name: necrotizing enterocolitis


subject: DRUGBANK:DB19249

object_name: Necrotizing Enterocolitis, AE


subject: DRUGBANK:DB19249

object_name: Feeding Intolerance


subject: DRUGBANK:DB19249

object_name: Feeding Intolerance, AE


subject: DRUGBANK:DB19249

object_name: Neonatal Late-Onset Sepsis


subject: CHEBI:6832

subject_name: Methocarbamol

object_name: liver cirrhosis


subject: UMLS:C0042210

subject_name: Vaccines

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5667038

subject_name: IL-12-expressing Exosome CDK-003

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:46783403

object_name: Dyspepsia, CTCAE


subject: UNII:05HYK3CV9N

subject_name: Linperlisib

object_name: autoimmune hemolytic anemia


subject: CHEBI:6413

subject_name: Letrozole

object_name: Early Pregnancy Loss


subject: CHEBI:6413

object_name: Miscarriage in first trimester


subject: CHEBI:6413

object_name: Miscarriage


subject: CHEBI:6413

object_name: spontaneous abortion


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:63610


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: osteoporosis


subject: UNII:AVK0I6HY2U

object_name: Encounter due to family history of osteoporosis


subject: UNII:AVK0I6HY2U

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:AVK0I6HY2U

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:AVK0I6HY2U

object_name: Osteoporosis of vertebrae


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: migraine


subject: PUBCHEM.COMPOUND:5281767

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: lymphedema


subject: CHEBI:6128

object_name: Lymphedema, CTCAE


subject: UNII:1Z08G7438A

subject_name: Dovramilast

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:177406

subject_name: CDDO-Me

object_name: chronic kidney disease


subject: CHEBI:177406

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:177406

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:53315588


subject: PUBCHEM.COMPOUND:53315588


subject: PUBCHEM.COMPOUND:53315588


subject: UMLS:C4722726


subject: UMLS:C4547951

object_name: eosinophilic esophagitis


subject: UMLS:C4547951

object_name: Eosinophilic infiltration of the esophagus


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:119915

subject_name: Fentanyl

object_name: post operative nausea and vomiting


subject: UMLS:C2697511


subject: UMLS:C2697511

object_name: lymphopenia


subject: CHEBI:67272

subject_name: Perifosine

object_name: Waldenstrom macroglobulinemia


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: adenomyosis


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Hyperkalemia, CTCAE


subject: CHEBI:17925

object_name: Hyperkalemia


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: UMLS:C3714501


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C5555006

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555006

object_name: Adult Solid Neoplasm


subject: UMLS:C5555006

object_name: Solid Neoplasm


subject: UMLS:C3275286

object_name: Acute myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: Fractures, Open


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: cerebrovascular disorder


subject: CHEBI:7915

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:9909681

subject_name: lasofoxifene

object_name: Osteopenia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: esophageal squamous cell carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Kala-Azar


subject: UMLS:C3714501

object_name: diabetic hyperglycaemia


subject: CHEBI:5931


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Sicca Syndrome


subject: CHEBI:74947

object_name: Xerostomia


subject: UMLS:C4055175

subject_name: Curcumin-based Gel

object_name: Stomatitis radiation


subject: UMLS:C4055175

object_name: Neck Carcinoma


subject: UMLS:C4055175

object_name: head and neck neoplasm


subject: UMLS:C4055175

object_name: head and neck cancer


subject: UMLS:C0038135

subject_name: Standard Preparations


subject: UMLS:C0038135


subject: UMLS:C0038135


subject: UMLS:C0038135


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Liquid Tumor


subject: CHEBI:4026

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E

object_name: leukemia


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:R30772KCU0

subject_name: Isatuximab


subject: UNII:R30772KCU0


subject: UNII:R30772KCU0

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:R30772KCU0

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:R30772KCU0

object_name: non-Hodgkin lymphoma


subject: UNII:R30772KCU0


subject: UNII:R30772KCU0


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: CHEBI:31824

subject_name: Mesna

object_name: plasma cell myeloma


subject: CHEBI:31824


subject: CHEBI:31824

object_name: Plasma cell myeloma refractory


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:5281767

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:5281767

object_name: abdominal aortic aneurysm


subject: PUBCHEM.COMPOUND:5281767

object_name: aortic aneurysm, familial abdominal, 1


subject: UNII:D87YGH4Z0Q

subject_name: Omacor

object_name: abdominal obesity-metabolic syndrome


subject: UNII:D87YGH4Z0Q

object_name: metabolic syndrome X


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Abdominal Neoplasms


subject: CHEBI:45863

object_name: Colon Neoplasm


subject: CHEBI:45863

object_name: Mesothelioma


subject: CHEBI:45863

object_name: mesothelial neoplasm


subject: CHEBI:45863

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: peritoneal neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UMLS:C2350618

subject_name: AGO 178

object_name: endogenous depression


subject: UMLS:C2350618

object_name: major depressive disorder


subject: UMLS:C1657522

subject_name: CeraVe Hydrating Cleanser

object_name: Complications of Diabetes Mellitus


subject: UMLS:C5917613

subject_name: CeraVe Moisturizing Cream


subject: CHEBI:53762

object_name: insomnia


subject: CHEBI:53762

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:53762

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:32315


subject: CHEBI:32315


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: tenosynovitis


subject: CHEBI:6456

subject_name: Lidocaine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: impaired renal function disease


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:47499

subject_name: Imipramine

object_name: Childhood Breast Carcinoma


subject: CHEBI:47499

object_name: breast carcinoma


subject: CHEBI:47499

object_name: breast cancer


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Diminished ovarian reserve


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C2987370

object_name: Solid Neoplasm


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Superficial vein thrombosis


subject: CHEBI:136049

subject_name: Mirodenafil

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:136049

object_name: Erectile dysfunction


subject: UMLS:C1871941


subject: UMLS:C1871941


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: UNII:37CQ2C7X93

object_name: myelofibrosis


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: primary peritoneal carcinoma


subject: UNII:68AYS9A614

object_name: papillary serous cystadenocarcinoma


subject: UNII:68AYS9A614

object_name: peritoneal carcinoma


subject: UNII:68AYS9A614

object_name: ovarian cancer


subject: UNII:68AYS9A614

object_name: ovarian carcinoma


subject: UNII:68AYS9A614

object_name: malignant epithelial tumor of ovary


subject: UNII:68AYS9A614

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: Ovarian High Grade Endometrioid Adenocarcinoma


subject: UNII:68AYS9A614

object_name: high grade ovarian serous adenocarcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: UMLS:C1831824

object_name: prostate carcinoma


subject: UMLS:C1831824

object_name: prostate cancer


subject: UNII:SE2KH7T06F

object_name: LEFT VENTRICULAR FUNCTION SYSTOLIC DYSFUNCTION


subject: UMLS:C2826229


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:37845

subject_name: growth hormone

object_name: hypopituitarism


subject: CHEBI:37845

object_name: concussion


subject: CHEBI:37845

object_name: traumatic encephalopathy


subject: CHEBI:37845

object_name: Hypopituitarism, CTCAE


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: CHEBI:188664

subject_name: Omecamtiv Mecarbil

object_name: Reduced ejection fraction co-occurrent and due to chronic heart failure


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: atrial fibrillation


subject: CHEBI:86158

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:86158

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:3312


subject: CHEBI:3312


subject: UNII:EGC16R10V0

subject_name: DALANTERCEPT

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2981815

subject_name: Dalantercept


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Job Syndrome


subject: UNII:2P471X1Z11

object_name: hyper-IgE syndrome


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Adult bronchiectasis


subject: CHEBI:62880

subject_name: Veliparib

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: meningococcal meningitis


subject: UMLS:C0728976

object_name: meningococcal infection


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C3859491

subject_name: Trumenba


subject: UMLS:C3859491


subject: CHEBI:35493

subject_name: antipyretic


subject: CHEBI:35493


subject: UMLS:C0003419

subject_name: Antipyretics


subject: UMLS:C0003419


subject: CHEBI:35480

subject_name: analgesic

object_name: agitated; state, acute reaction to stress


subject: UMLS:C4722089

subject_name: Analgesics [TC]


subject: CHEBI:50919

subject_name: antiemetic


subject: UMLS:C0003297

subject_name: Antiemetics


subject: CHEBI:94573

subject_name: Zibotentan

object_name: lung cancer


subject: CHEBI:94573

object_name: lung neoplasm


subject: CHEBI:94573

object_name: lung carcinoma


subject: CHEBI:94573

object_name: non-small cell lung carcinoma


subject: UMLS:C5203461

subject_name: Paricalcitol Liquid Injection

object_name: secondary hyperparathyroidism


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: high grade B-cell lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: B-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:71226663

object_name: primary mediastinal large B-cell lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: PUBCHEM.COMPOUND:71226663

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R

object_name: grade 3A follicular lymphoma


subject: UNII:M694U7167K

object_name: heart disorder


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Demonstrates adequate pain control


subject: CHEBI:233446

subject_name: suzetrigine


subject: UMLS:C4727690

object_name: Androgen excess


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: Acute appendicitis NOS (disorder)


subject: MESH:C000620717

subject_name: kuntai capsule

object_name: Turner syndrome


subject: MESH:C000620717

object_name: primary ovarian failure


subject: MESH:C000620717

object_name: premature menopause


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:50005

subject_name: trans-stilbene oxide

object_name: Crohn disease


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:63791

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:63791

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:63791

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63791

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

subject_name: Romidepsin

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:61080

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:61080

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:61080

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61080

object_name: anaplastic large cell lymphoma


subject: CHEBI:61080

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:61080

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:61080

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:61080

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:61080

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61080

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C0963679

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C0963679

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C0963679

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C0963679

object_name: anaplastic large cell lymphoma


subject: UMLS:C0963679

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C0963679

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C0963679

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C0963679

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0963679

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C0963679

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0963679

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:8707

subject_name: Quetiapine

object_name: mood disorder


subject: GTOPDB:11827

subject_name: telitacicept

object_name: Myasthenia Gravis, Generalized


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:85990

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5435446

object_name: acne


subject: CHEBI:31198

subject_name: Ambroxol hydrochloride

object_name: Critical Illness


subject: CHEBI:31198

object_name: Hospital acquired pneumonia


subject: CHEBI:31198

object_name: Community-Acquired Pneumonia


subject: UNII:CC995ZMV90

subject_name: AMBROXOL HYDROCHLORIDE


subject: UNII:CC995ZMV90


subject: UNII:CC995ZMV90


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:135590


subject: CHEBI:135590


subject: UNII:7YM030A71C

object_name: hepatitis C


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Heberden node


subject: CHEBI:6456

object_name: osteoarthritis, hand


subject: CHEBI:6456

object_name: Acquired trigger finger


subject: CHEBI:6456

object_name: trigger thumb


subject: CHEBI:17188

subject_name: nucleoside 5'-monophosphate

object_name: intervertebral disk degenerative disorder


subject: CHEBI:17188

object_name: lumbar disk degenerative disorder


subject: CHEBI:17188

object_name: Degenerative spondylolisthesis


subject: CHEBI:17188

object_name: spinal stenosis


subject: CHEBI:25608

subject_name: nucleoside phosphate


subject: CHEBI:25608


subject: CHEBI:25608


subject: CHEBI:25608


subject: CHEBI:7307

subject_name: Methyl pyrrolidone


subject: CHEBI:7307


subject: CHEBI:7307


subject: CHEBI:7307


subject: UMLS:C4288167

subject_name: Sumac/Black Cumin Powder

object_name: Nausea, CTCAE_5


subject: UMLS:C4288167

object_name: Nausea


subject: UMLS:C4288167

object_name: Nausea, CTCAE_3


subject: UMLS:C4288167

object_name: Vomiting, CTCAE


subject: UMLS:C4288167

object_name: Vomiting


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Congenital postural scoliosis


subject: UMLS:C0445115

object_name: scoliosis


subject: UMLS:C0445115

object_name: Scoliosis, CTCAE


subject: UMLS:C0445115

object_name: idiopathic scoliosis


subject: UMLS:C0445115

object_name: adolescent idiopathic scoliosis


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: CHEBI:4466


subject: CHEBI:4466


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:129316491

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:129316491

object_name: amyotrophic lateral sclerosis


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: CHEBI:10023

subject_name: Voriconazole

object_name: scedosporiosis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: thyroid tumor


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Crohn disease


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Kaposi Sarcoma


subject: UMLS:C2346820


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:2376

subject_name: acarbose

object_name: renal carcinoma


subject: CHEBI:2376

object_name: kidney neoplasm


subject: CHEBI:2376

object_name: kidney cancer


subject: UMLS:C0796512

subject_name: CCI 779

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:79699

subject_name: Temsirolimus


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: Thermal burn


subject: PR:000002327

object_name: Burn injury


subject: CHEBI:95341

subject_name: Baricitinib

object_name: diabetic kidney disease


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: sarcoidosis


subject: CHEBI:135949

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:46662

subject_name: mineral

object_name: malnutrition


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: Uncomplicated malaria


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: follicular lymphoma


subject: UMLS:C1328139


subject: UNII:CRR8E37XOB

object_name: renal cell carcinoma


subject: UMLS:C1569206


subject: CHEBI:190523

subject_name: fructooligosaccharide

object_name: Functional constipation


subject: MESH:C116580


subject: UMLS:C3244459

subject_name: mannitol inhalation kit

object_name: cough variant asthma


subject: UMLS:C3244459

object_name: Cough


subject: UMLS:C3244459

object_name: Cough, CTCAE


subject: UMLS:C3244459

object_name: asthma


subject: CHEBI:6804

subject_name: Methacholine


subject: CHEBI:6804


subject: CHEBI:6804


subject: CHEBI:88428


subject: CHEBI:88428


subject: CHEBI:88428


subject: CHEBI:88428


subject: CHEBI:80254

subject_name: Melanin-concentrating hormone


subject: CHEBI:80254


subject: CHEBI:80254


subject: CHEBI:80254


subject: CHEBI:63918

subject_name: Artesunate

object_name: latent tuberculosis infection


subject: CHEBI:63918

object_name: HIV infection


subject: CHEBI:18231

subject_name: arsenic acid


subject: CHEBI:18231


subject: UniProtKB:P0AF61

subject_name: GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


subject: UniProtKB:P0AF61


subject: PR:000002156


subject: PR:000002156


subject: PR:000006315

subject_name: protein artemis


subject: PR:000006315


subject: PR:000003846

subject_name: agouti-related protein


subject: PR:000003846


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: UMLS:C3714638


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: UMLS:C0796615

subject_name: Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine

object_name: prostate carcinoma


subject: UMLS:C0796615

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE

object_name: Dysphagia


subject: PUBCHEM.COMPOUND:49800030

object_name: Dysphagia, CTCAE


subject: PUBCHEM.COMPOUND:49800030

object_name: Prolapsed cervical intervertebral disc


subject: PUBCHEM.COMPOUND:49800030

object_name: intervertebral disk degenerative disorder


subject: PUBCHEM.COMPOUND:49800030

object_name: cervical disk degenerative disorder


subject: PUBCHEM.COMPOUND:49800030

object_name: Osteoarthritis of cervical spine


subject: PUBCHEM.COMPOUND:49800030

object_name: Cervical myelopathy


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: ovarian carcinosarcoma


subject: CHEBI:72317

object_name: carcinosarcoma of vagina


subject: CHEBI:72317

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:72317

object_name: uterine carcinosarcoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:75722

subject_name: Tramadol

object_name: ankylosing spondylitis


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:104747

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:3X48A86C8K

subject_name: polysaccharide-K


subject: UNII:3X48A86C8K


subject: UNII:3X48A86C8K


subject: PR:000016049

subject_name: serine/threonine-protein kinase TAO2


subject: PR:000016049


subject: PR:000016049


subject: PR:000014729

subject_name: seizure 6-like protein 2


subject: PR:000014729


subject: PR:000014729


subject: PR:000015742

subject_name: serine/threonine-protein kinase 16


subject: PR:000015742


subject: PR:000015742


subject: UMLS:C0003204

subject_name: Anti-Infective Agents

object_name: leukopenia


subject: UMLS:C0003204

object_name: neutropenia


subject: UMLS:C0003204

object_name: Immunosuppression


subject: UMLS:C0003204

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0003204

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0003204

object_name: cancer


subject: UMLS:C0003204

object_name: neoplasm


subject: UMLS:C3540713

subject_name: ANTIINFECTIVE DRUGS, OTOLOGIC


subject: UMLS:C3540713


subject: UMLS:C3540713


subject: UMLS:C3540713


subject: UMLS:C3540713


subject: UMLS:C3540713


subject: UMLS:C3540713


subject: UMLS:C3540714

subject_name: ANTIINFECTIVE OPHTHALMOLOGICS


subject: UMLS:C3540714


subject: UMLS:C3540714


subject: UMLS:C3540714


subject: UMLS:C3540714


subject: UMLS:C3540714


subject: UMLS:C3540714


subject: UMLS:C3540715

subject_name: Antiinfective irrigating solutions


subject: UMLS:C3540715


subject: UMLS:C3540715


subject: UMLS:C3540715


subject: UMLS:C3540715


subject: UMLS:C3540715


subject: UMLS:C3540715


subject: UMLS:C3540716

subject_name: ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC


subject: UMLS:C3540716


subject: UMLS:C3540716


subject: UMLS:C3540716


subject: UMLS:C3540716


subject: UMLS:C3540716


subject: UMLS:C3540716


subject: CHEBI:30418

subject_name: Astatane

object_name: Sepsis


subject: CHEBI:30418

object_name: Sepsis, CTCAE


subject: CHEBI:30418

object_name: necrotizing soft tissue infection


subject: UMLS:C0062773

subject_name: histone acetyltransferase


subject: UMLS:C0062773


subject: UMLS:C0062773


subject: UniProtKB:Q9M2N5

subject_name: DSLE_ARATH Zinc finger BED domain-containing protein DAYSLEEPER (sprot)


subject: UniProtKB:Q9M2N5


subject: UniProtKB:Q9M2N5


subject: PR:000016450

subject_name: transmembrane protease serine 11D


subject: PR:000016450


subject: PR:000016450


subject: CHEBI:6427

subject_name: Leuprolide

object_name: hypogonadism


subject: UMLS:C5543952

object_name: Alzheimer disease type 1


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Reduced


subject: UNII:7D0YB67S97

object_name: psoriatic arthritis


subject: UNII:7D0YB67S97

object_name: Withdrawal


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: UNII:FYS6T7F842


subject: UNII:N5UK68MGDZ

subject_name: Apremilast


subject: UNII:N5UK68MGDZ


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB


subject: UNII:UMD07X179E


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: CHEBI:4875

subject_name: Etanercept


subject: CHEBI:4875


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: UNII:91X1KLU43E


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UNII:B72HH48FLU


subject: UNII:B72HH48FLU


subject: UNII:BTY153760O

subject_name: Ixekizumab


subject: UNII:BTY153760O


subject: CHEBI:6402

subject_name: Leflunomide


subject: CHEBI:6402


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: UNII:DLG4EML025


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine


subject: PUBCHEM.COMPOUND:5339


subject: PUBCHEM.COMPOUND:5339


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: CHEBI:71200


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: UNII:FU77B4U5Z0


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: sickle cell disease


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: tropical spastic paraparesis


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: endometrial cancer


subject: UNII:2S9ZZM9Q9V

object_name: uterine corpus cancer


subject: UNII:2S9ZZM9Q9V

object_name: endometrial carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: peritoneum cancer


subject: CHEBI:6129

object_name: ovarian cancer


subject: CHEBI:6129

object_name: ovarian neoplasm


subject: CHEBI:6129

object_name: ovarian carcinoma


subject: CHEBI:6129

object_name: fallopian tube carcinoma


subject: CHEBI:6129

object_name: fallopian tube cancer


subject: CHEBI:7421

subject_name: NAC

object_name: Ischemic hepatitis


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4053580

subject_name: Anti-CD20-engineered Toxin Body MT-3724


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: oropharyngeal carcinoma


subject: UMLS:C4086546

object_name: oropharynx cancer


subject: UMLS:C4086546

object_name: Oral-pharyngeal dysphagia


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: kidney failure


subject: PUBCHEM.COMPOUND:23297360

subject_name: Nestorone

object_name: Uses contraception (finding)


subject: UMLS:C0283986


subject: CHEBI:135041

subject_name: phenbenzamine

object_name: Failure to thrive in infant


subject: CHEBI:135041

object_name: Undergrowth


subject: CHEBI:135041

object_name: Failure to Thrive


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:91083

subject_name: Romiplostim

object_name: Thalassemia in children


subject: UMLS:C1505595


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: glioma susceptibility 1


subject: GTOPDB:9592

object_name: adult oligodendroglioma


subject: GTOPDB:9592

object_name: oligodendroglioma


subject: GTOPDB:9592

object_name: childhood oligodendroglioma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:125427

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:17823

subject_name: Calcitriol


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: Childhood Breast Carcinoma


subject: UniProtKB:P53767

object_name: breast carcinoma


subject: UniProtKB:P53767

object_name: breast cancer


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: PR:000002112


subject: PR:000002112


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: malignant pancreatic neoplasm


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: pemphigus vulgaris


subject: UMLS:C4087084

subject_name: TRX 818

object_name: liver carcinoma


subject: UMLS:C4087084

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:59527

object_name: Uses contraception (finding)


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Adult Solid Neoplasm


subject: CHEBI:177833

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:177833

object_name: Carcinoma breast stage IV


subject: CHEBI:177833

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:177833

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:177833

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:177833

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:177833

object_name: Breast cancer recurrent


subject: CHEBI:177833

object_name: triple-negative breast carcinoma


subject: CHEBI:177833

object_name: Progesterone Receptor Negative


subject: CHEBI:177833

object_name: male breast carcinoma


subject: CHEBI:177833

object_name: Estrogen Receptor Negative


subject: CHEBI:177833

object_name: HER2/Neu Negative


subject: UMLS:C0764377

object_name: Adult Solid Neoplasm


subject: UMLS:C0764377

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0764377

object_name: Carcinoma breast stage IV


subject: UMLS:C0764377

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0764377

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0764377

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0764377

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0764377

object_name: Breast cancer recurrent


subject: UMLS:C0764377

object_name: triple-negative breast carcinoma


subject: UMLS:C0764377

object_name: Progesterone Receptor Negative


subject: UMLS:C0764377

object_name: male breast carcinoma


subject: UMLS:C0764377

object_name: Estrogen Receptor Negative


subject: UMLS:C0764377

object_name: HER2/Neu Negative


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:195280

subject_name: Artemether

object_name: Malaria, Vivax


subject: UNII:IHB5WLO51Q

subject_name: PIPERAQUINE TETRAPHOSPHATE


subject: UMLS:C3281828

subject_name: Piperaquine phosphate


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13085

object_name: breast carcinoma


subject: GTOPDB:13085

object_name: breast cancer


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: GTOPDB:2943

subject_name: secretin

object_name: acute pancreatitis


subject: CHEBI:232390


subject: UMLS:C4287766

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4287766

object_name: Embolism, Tumor


subject: UMLS:C4287766

object_name: Neoplasm Metastasis


subject: UMLS:C4287766

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: monoclonal gammopathy of uncertain significance


subject: PUBCHEM.COMPOUND:5281767

object_name: smoldering plasma cell myeloma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:9815560

subject_name: Estreptoquinasa

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:9815560

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:9815560

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:9815560

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:9815560

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:9815560

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:9815560

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:9815560

object_name: heart disorder


subject: UNII:8X1OXL3SNU

subject_name: STREPTOKINASE


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UMLS:C0038418

subject_name: streptokinase


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C0360377

subject_name: Vancomycin powder

object_name: Surgical Wound Infection


subject: UMLS:C0360377

object_name: Neuropathic spinal arthropathy


subject: UMLS:C0360377

object_name: Spinal Neoplasm


subject: UMLS:C0360377

object_name: Physical trauma


subject: UMLS:C0360377

object_name: Injury


subject: UMLS:C0360377

object_name: Trauma


subject: UMLS:C4053604

subject_name: Phosphaplatin PT-112

object_name: biliary tract cancer


subject: UMLS:C4053604

object_name: liver carcinoma


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5206815


subject: UMLS:C5706347

subject_name: Anti-Claudin18.2/Anti-CD3 Bispecific Antibody QLS31905


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Permanent atrial fibrillation


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:78140854

object_name: myoclonic dystonia 11


subject: CHEBI:9014

subject_name: Salsalate

object_name: Inflammation


subject: CHEBI:9014

object_name: coronary microvascular disorder


subject: CHEBI:64312

subject_name: Memantine

object_name: cancer


subject: CHEBI:64312

object_name: neoplasm


subject: CHEBI:59527

object_name: arthritis


subject: CHEBI:59527

object_name: Arthritis, CTCAE


subject: CHEBI:59527

object_name: Lyme Arthritis


subject: CHEBI:59527

object_name: Lyme disease


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:91939


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: Restless legs


subject: CHEBI:131391


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Progressive massive fibrosis


subject: CHEBI:32016

object_name: silicosis


subject: CHEBI:32016

object_name: Complicated silicosis


subject: CHEBI:167204

subject_name: Mosapride

object_name: Chronic constipation


subject: CHEBI:28498

subject_name: Acadesine

object_name: Abnormal left ventricular function


subject: CHEBI:28498

object_name: myocardial infarction


subject: CHEBI:28498

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:28498

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:28498

object_name: stroke disorder


subject: CHEBI:28498

object_name: cerebrovascular disorder


subject: CHEBI:28498

object_name: Stroke (heart beat)


subject: CHEBI:28498

object_name: Stroke, CTCAE


subject: CHEBI:5147

subject_name: Formoterol

object_name: bronchitis


subject: CHEBI:5147

object_name: Acute bronchitis


subject: CHEBI:5147

object_name: emphysema


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:408174


subject: CHEBI:408174


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium


subject: PUBCHEM.COMPOUND:3086655


subject: PUBCHEM.COMPOUND:3086655


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: PUBCHEM.COMPOUND:11431811


subject: PUBCHEM.COMPOUND:11431811


subject: CHEBI:35553

subject_name: Perhexiline

object_name: hypertrophic cardiomyopathy


subject: CHEBI:35553

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:16755

subject_name: chenodiol

object_name: cerebrotendinous xanthomatosis


subject: CHEBI:32188

subject_name: Tegafur

object_name: esophageal squamous cell carcinoma


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG

object_name: non-small cell lung carcinoma


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: Oral ulcer


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: CHEBI:17439


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: chronic kidney disease


subject: CHEBI:194186

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:194186

object_name: Melanoma of the Ciliary Body and Choroid pT2d TNM Finding v7


subject: CHEBI:194186

object_name: T2d TNM Finding


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:14907381

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:DPT0O3T46P


subject: CHEBI:60775

subject_name: Verteporfin


subject: CHEBI:60775


subject: CHEBI:60775


subject: CHEBI:60775


subject: CHEBI:60775


subject: CHEBI:60775


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: UMLS:C5417929

subject_name: IMU 838


subject: UMLS:C2352201

subject_name: Conbercept

object_name: gastroesophageal cancer


subject: UMLS:C2352201

object_name: Stomach cancer


subject: UMLS:C2352201

object_name: gastric cancer


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Non dystrophic myotonia


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: UNII:BLP1XA3FZA

subject_name: Venglustat

object_name: disorders of sphingolipid metabolism


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Growth & development aspects


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Opioid use, unspecified


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:50634

object_name: cerebrospinal fluid leak


subject: CHEBI:27690

subject_name: Acetazolamide


subject: GTOPDB:4934

subject_name: G-CSF

object_name: severe neurodegenerative syndrome with lipodystrophy


subject: GTOPDB:4934

object_name: liver cirrhosis


subject: GTOPDB:4934

object_name: marasmus


subject: GTOPDB:4934

object_name: malnutrition


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Recurrent Endometrial Cancer


subject: UNII:KXG2PJ551I

object_name: ARID1A gene mutation


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C5417840

subject_name: ATR Kinase Inhibitor M1774

object_name: endometrial cancer


subject: UMLS:C5417840

object_name: uterine corpus cancer


subject: UMLS:C5417840

object_name: endometrial carcinoma


subject: UMLS:C5417840


subject: UMLS:C5417840


subject: UMLS:C2713349

subject_name: Nebido

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C2713349

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate


subject: PUBCHEM.COMPOUND:21873174


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C4725113

object_name: cervical cancer


subject: UMLS:C4725113

object_name: cervical carcinoma


subject: UMLS:C4725113

object_name: cervical intraepithelial neoplasia grade 2/3


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: osteoarthritis, hip


subject: CHEBI:9667

object_name: osteoarthritis susceptibility 5


subject: UMLS:C3849846

subject_name: technetium 99m etarfolatide

object_name: ovarian cancer


subject: UMLS:C3849846

object_name: ovarian neoplasm


subject: UMLS:C3827129

subject_name: Folate Receptor-Targeted Tubulysin Conjugate EC1456


subject: UMLS:C3827129


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: heart failure


subject: CHEBI:84094

object_name: Heart Failure, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:2735

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C2981830

subject_name: SGN 75

object_name: renal cell carcinoma


subject: UMLS:C2981830

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C2981830

object_name: non-Hodgkin lymphoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Renal Cell Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Renal cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Renal cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage III renal cell cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Renal Cell Cancer AJCC v7


subject: GTOPDB:6596

subject_name: etaracizumab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:6596

object_name: clear cell renal carcinoma


subject: GTOPDB:6596

object_name: renal cell adenocarcinoma


subject: GTOPDB:6596


subject: GTOPDB:6596


subject: GTOPDB:6596

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: GTOPDB:6596


subject: GTOPDB:6596


subject: GTOPDB:6596


subject: GTOPDB:6596

object_name: Stage III Renal Cell Cancer AJCC v8


subject: GTOPDB:6596


subject: GTOPDB:6596


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C0740110

subject_name: Testoviron

object_name: dysthymic disorder


subject: CHEBI:27436

subject_name: Methyltestosterone


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:2307

object_name: COPD, severe early onset


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: UNII:NWR3BEB8PA

subject_name: Iferanserin

object_name: internal hemorrhoid


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:233362

object_name: thyroid tumor


subject: CHEBI:233362

object_name: thyroid gland carcinoma


subject: CHEBI:233362

object_name: thyroid cancer


subject: CHEBI:3286

subject_name: Cabergoline

object_name: migraine


subject: CHEBI:3286

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: obstructive sleep apnea syndrome


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Complication of transplanted liver


subject: CHEBI:137245

subject_name: Asp-Pro


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Retrognathia


subject: UNII:FO8S2IW40N

subject_name: larazotide acetate

object_name: long COVID-19


subject: UNII:FO8S2IW40N

object_name: Chronic post-COVID-19 syndrome


subject: UMLS:C1964933


subject: UMLS:C1964933


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: oral cavity squamous cell carcinoma


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: inflammatory bowel disease


subject: UNII:N3KQ8A1E0X

object_name: Postoperative ileus


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Analgesic adverse reaction


subject: UMLS:C3255200

subject_name: aflibercept ophthalmic

object_name: neovascular glaucoma


subject: UMLS:C3255200

object_name: Disorder of intraocular pressure


subject: UMLS:C3255200

object_name: Intraocular Pressure


subject: UMLS:C3255200

object_name: Glaucoma secondary to eye inflammation


subject: UMLS:C3255200

object_name: Vascular endothelial growth factor overexpression


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:8768

object_name: amyotrophic lateral sclerosis


subject: PR:000003774

object_name: type 2 diabetes mellitus


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: epidermolysis bullosa


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: CNS disorder


subject: PUBCHEM.COMPOUND:6419987

subject_name: IFENPRODIL TARTRATE

object_name: post-traumatic stress disorder


subject: CHEBI:93829

subject_name: Ifenprodil


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Soft Tissue Sarcoma


subject: UNII:C825F38B80

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:C825F38B80

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5447751

subject_name: SHP2 Inhibitor BBP-398


subject: UMLS:C5447751


subject: CHEBI:178199

subject_name: Sotorasib


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: AIDS


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: nasopharyngeal neoplasm


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: alcoholic hepatitis


subject: UMLS:C2703131

subject_name: CAL 101

object_name: interstitial lung disease 1


subject: UMLS:C2703131

object_name: interstitial lung disease 2


subject: CHEBI:94721

subject_name: Triflusal


subject: CHEBI:94721

object_name: Insulin resistance


subject: CHEBI:4285

subject_name: DCI


subject: CHEBI:4285


subject: UNII:U7NOE2K4M2

subject_name: Dichloroisoproterenol


subject: UNII:U7NOE2K4M2


subject: CHEBI:27372


subject: CHEBI:27372


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: bronchiolitis


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C4519731

object_name: heart failure


subject: UMLS:C4519731

object_name: Heart Failure, CTCAE


subject: UMLS:C4519731

object_name: kidney disorder


subject: UMLS:C4519731

object_name: impaired renal function disease


subject: UMLS:C4086499

subject_name: Huaier Extract Granule


subject: UMLS:C4086499


subject: UMLS:C4086499

object_name: Glomerulopathy


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:8673

object_name: Autoimmunity


subject: CHEBI:8673

object_name: lymphoproliferative syndrome


subject: CHEBI:8673

object_name: lymphoid system disorder


subject: CHEBI:8673

object_name: Lymphadenopathy


subject: CHEBI:6801

subject_name: Metformin

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEMBL.COMPOUND:CHEMBL4297772

object_name: B-cell neoplasm


subject: UMLS:C0282554

subject_name: chemokine


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: primary brain neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Recurrent Brain Neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEBI:16335

subject_name: Adenosine

object_name: myocardial ischemia


subject: CHEBI:16335

object_name: Family history of ischemic heart disease


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:4653


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Left ventricular hypertrophy


subject: UMLS:C1145201

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: prostate carcinoma


subject: UNII:OX5LRQ5H6K

object_name: prostate cancer


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: CHEBI:68554

subject_name: Deferiprone

object_name: kidney failure


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: Weight loss


subject: UNII:913P6LK81M

object_name: Weight Loss, CTCAE


subject: UNII:913P6LK81M

object_name: Weight Change


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Childhood Breast Carcinoma


subject: CHEBI:9150

object_name: breast carcinoma


subject: CHEBI:9150

object_name: breast cancer


subject: GTOPDB:10492

subject_name: envafolimab


subject: GTOPDB:10492


subject: GTOPDB:10492

object_name: CDK12 Gene Mutation


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Infant, Premature, Diseases


subject: MESH:C000720267

object_name: viral respiratory tract infection


subject: UNII:EJB8KD4JLL

object_name: systemic inflammatory response syndrome


subject: UMLS:C4079739


subject: GTOPDB:10492

object_name: pediatric osteosarcoma


subject: GTOPDB:10492

object_name: Osteosarcoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: CHEBI:3347

subject_name: Candesartan

object_name: migraine


subject: CHEBI:3347

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:H18SKU3289

subject_name: visilizumab

object_name: graft versus host disease


subject: UMLS:C1135148

subject_name: Nuvion


subject: UNII:41XGO0VS1U

object_name: Klatskin Tumor


subject: CHEBI:35480

subject_name: analgesic

object_name: Disorder of shoulder


subject: CHEBI:6504

object_name: prostate carcinoma


subject: CHEBI:6504

object_name: prostate cancer


subject: UMLS:C2367757

subject_name: human papilloma virus vaccine, bivalent

object_name: common wart


subject: UMLS:C2367757

object_name: Human Papilloma Virus, Female


subject: UMLS:C2367757

object_name: Human Papilloma Virus, Male


subject: UMLS:C3640822

object_name: Stage I Prostate Cancer AJCC v6


subject: UMLS:C3640822

object_name: Prostate cancer stage I


subject: UMLS:C3640822

object_name: Stage I Prostate Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage I Prostate Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C3640822

object_name: Carcinoma of the prostate stage III


subject: UMLS:C3640822

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C3640822

object_name: Stage I Renal Cell Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage I Renal Cell Carcinoma


subject: UMLS:C3640822

object_name: Stage II Renal Cell Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage II Renal Cell Cancer


subject: UMLS:C3640822

object_name: Stage II Renal Cell Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage III renal cell cancer


subject: UMLS:C3640822

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C3640822

object_name: Bladder transitional cell carcinoma stage II


subject: UMLS:C3640822

object_name: infiltrating bladder urothelial carcinoma


subject: PUBCHEM.COMPOUND:6918304

subject_name: Naproxcinod

object_name: kidney failure


subject: PUBCHEM.COMPOUND:6918304

object_name: Renal Failure, CTCAE


subject: UMLS:C5555005

subject_name: Zelenectide Pevedotin

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5555005

object_name: bladder tumor


subject: UMLS:C5555005

object_name: triple-negative breast carcinoma


subject: UMLS:C5555005

object_name: breast neoplasm


subject: UMLS:C5555005

object_name: ovarian cancer


subject: UMLS:C5555005

object_name: ovarian neoplasm


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Aicardi-Goutieres syndrome


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Childhood Breast Carcinoma


subject: UNII:M89N0Q7EQR

object_name: breast carcinoma


subject: UNII:M89N0Q7EQR

object_name: breast cancer


subject: UNII:M89N0Q7EQR


subject: UNII:M89N0Q7EQR

object_name: urinary bladder carcinoma


subject: UNII:M89N0Q7EQR

object_name: urinary bladder cancer


subject: UNII:M89N0Q7EQR

object_name: childhood bladder carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form

object_name: renal carcinoma


subject: PR:000015975

object_name: kidney cancer


subject: PR:000015975

object_name: cervical cancer


subject: PR:000015975

object_name: cervical carcinoma


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975


subject: PR:000015975

object_name: melanoma


subject: UMLS:C0034790

subject_name: T-Cell Receptor


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790

object_name: bladder tumor


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:141450

subject_name: Trp-Thr


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:5XGC17ZKUF

subject_name: Radiprodil

object_name: Focal cortical dysplasia


subject: UNII:5XGC17ZKUF

object_name: tuberous sclerosis


subject: UNII:5XGC17ZKUF

object_name: situs inversus


subject: UNII:5XGC17ZKUF

object_name: tuberous sclerosis 1


subject: CHEBI:8707

subject_name: Quetiapine

object_name: cocaine abuse


subject: CHEBI:177833

subject_name: Cilengitide

object_name: glioblastoma


subject: CHEBI:177833

object_name: Childhood Glioblastoma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: CHEBI:15640

subject_name: Leucovorin

object_name: medulloblastoma


subject: CHEBI:15640

object_name: childhood medulloblastoma


subject: CHEBI:15640

object_name: adult medulloblastoma


subject: CHEBI:15640

object_name: Untreated Childhood Pineoblastoma


subject: CHEBI:15640

object_name: large cell medulloblastoma


subject: CHEBI:15640

object_name: Anaplastic Medulloblastoma


subject: CHEBI:15640

object_name: supratentorial primitive neuroectodermal tumor


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:16VY3TM7ZO

object_name: Carcinoma of the prostate stage IV


subject: UNII:16VY3TM7ZO

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:16VY3TM7ZO

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:6121

subject_name: Ketamine

object_name: Postoperative depression


subject: CHEBI:23044

subject_name: carotenoid

object_name: Prediabetes


subject: CHEBI:23044

object_name: glucose intolerance


subject: CHEBI:23044

object_name: Impaired glucose tolerance


subject: CHEBI:23044

object_name: aneurysm


subject: CHEBI:35147

subject_name: alpha-Carotene


subject: CHEBI:35147


subject: CHEBI:35147


subject: CHEBI:35147


subject: CHEBI:84500

subject_name: varenicline

object_name: Recurrence


subject: CHEBI:84500

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:84500

object_name: Recurrent disease


subject: CHEBI:84500

object_name: Recurrent tumor


subject: CHEBI:84500

object_name: substance-related disorder


subject: UMLS:C5551665

subject_name: Hibiscus sabdariffa whole extract

object_name: hypertension


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: common variable immunodeficiency


subject: UMLS:C0085297

object_name: Acquired Hypogammaglobulinemia


subject: UMLS:C0085297

object_name: agammaglobulinemia


subject: UMLS:C0085297

object_name: syndromic agammaglobulinemia


subject: CHEBI:91512

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:91512

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91512

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: CHEBI:71019


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Decreased liver function


subject: CHEBI:48923

subject_name: erythromycin

object_name: pancreatitis


subject: CHEBI:48923

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:48923

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Opiate Abuse


subject: UMLS:C0024808

subject_name: Marihuana


subject: GTOPDB:8415

subject_name: tanezumab

object_name: endometriosis


subject: UNII:EQL0E9GCX1


subject: UMLS:C2346819


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: autoimmune thrombocytopenia


subject: UNII:AG9MHG098Z

object_name: thrombocytopenia due to immune destruction


subject: UNII:AG9MHG098Z

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:45783

subject_name: Imatinib

object_name: Atopic rhinitis


subject: CHEBI:45783

object_name: Hay fever


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: tendinitis


subject: PUBCHEM.COMPOUND:2367

object_name: bursitis


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: UNII:6029HGL0QP

subject_name: fluorocholine

object_name: primary hyperparathyroidism


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: hormone-resistant prostate carcinoma


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Miscarriage


subject: UNII:L500PR95QA

object_name: spontaneous abortion


subject: UNII:L500PR95QA

object_name: infertility


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: triple-negative breast carcinoma


subject: GTOPDB:12966

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: Dysfunction of urinary bladder


subject: CHEBI:135920

object_name: Urinary incontinence


subject: CHEBI:135920

object_name: Urinary Incontinence, CTCAE 5.0


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: irritable bowel syndrome


subject: UMLS:C5666890

subject_name: BTK Degrader BGB-16673

object_name: B-Cell Malignant Neoplasm


subject: UMLS:C5666890

object_name: refractory malignant neoplasm


subject: UMLS:C5666890

object_name: Recurrent Carcinoma


subject: UMLS:C5666890

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5666890

object_name: B-cell neoplasm


subject: UNII:06P3KLK2J8

subject_name: Glofitamab


subject: UNII:06P3KLK2J8


subject: UNII:06P3KLK2J8


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: UMLS:C4725069


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX


subject: CHEMBL.COMPOUND:CHEMBL5314951


subject: CHEMBL.COMPOUND:CHEMBL5314951


subject: CHEMBL.COMPOUND:CHEMBL5314951


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: DRUGBANK:DB18092

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB18092

object_name: breast carcinoma


subject: DRUGBANK:DB18092

object_name: breast cancer


subject: DRUGBANK:DB18092

object_name: Carcinoma breast stage IV


subject: CHEBI:2948

subject_name: Azathioprine

object_name: lupus nephritis


subject: CHEBI:28830

subject_name: Chlorambucil

object_name: splenic marginal zone lymphoma


subject: CHEBI:28830

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:28830

object_name: lymphoplasmacytic lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: glioma


subject: UMLS:C0376659

object_name: malignant glioma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: poisoning


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:27594

subject_name: Graphite


subject: UNII:DIO3JT9G2P

subject_name: Tin protoporphyrin IX

object_name: acute kidney failure


subject: UNII:DIO3JT9G2P

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0244221


subject: UMLS:C0244221


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Opioid toxicity


subject: CHEBI:8802

object_name: Hypoventilation


subject: CHEBI:8802

object_name: Miosis


subject: CHEBI:23359

subject_name: colchicine

object_name: acute myocardial infarction


subject: CHEBI:23359

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:231356

subject_name: Varlitinib

object_name: Solid Neoplasm


subject: UMLS:C4732973


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: ST-elevation myocardial infarction


subject: UNII:WGD229O42W

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Algodystrophic Syndrome


subject: CHEBI:22652

object_name: complex regional pain syndrome type 1


subject: CHEBI:22652

object_name: complex regional pain syndrome


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: psoriasis vulgaris


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: Nail Matrix Nevus


subject: CHEBI:14648

subject_name: NMN(+)


subject: UMLS:C1384663

object_name: Childhood Breast Carcinoma


subject: UMLS:C1384663

object_name: breast carcinoma


subject: UMLS:C1384663

object_name: breast cancer


subject: PUBCHEM.COMPOUND:78080258

subject_name: Odalasvir

object_name: chronic hepatitis C virus infection


subject: UMLS:C3640932

subject_name: WT1 Peptide Vaccine WT2725

object_name: cancer


subject: UMLS:C3640932

object_name: neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: adult hepatocellular carcinoma


subject: CHEBI:231614

object_name: liver cancer


subject: CHEBI:231614

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:3641

subject_name: Chlorotrianisene


subject: CHEBI:3641


subject: CHEBI:3641


subject: UMLS:C0723595

subject_name: Tace


subject: UMLS:C0723595


subject: UMLS:C0723595


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: autoimmune thrombocytopenia


subject: UNII:SQ8A3S5101

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C4733669

subject_name: Monoclonal Microbial EDP1503

object_name: melanoma


subject: UMLS:C4733669

object_name: skin melanoma